Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

MLA

Diener, Hans-Christoph, et al. “Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.” The New England Journal of Medicine, vol. 380, no. 20, May 2019, pp. 1906–17. EBSCOhost, https://doi.org/10.1056/NEJMoa1813959.

APA

Diener, H.-C., Sacco, R. L., Easton, J. D., Granger, C. B., Bernstein, R. A., Uchiyama, S., Kreuzer, J., Cronin, L., Cotton, D., Grauer, C., Brueckmann, M., Chernyatina, M., Donnan, G., Ferro, J. M., Grond, M., Kallmünzer, B., Krupinski, J., Lee, B.-C., Lemmens, R., … Toyoda, K. (2019). Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. The New England Journal of Medicine, 380(20), 1906–1917. https://doi.org/10.1056/NEJMoa1813959

Chicago

Diener, Hans-Christoph, Ralph L Sacco, J Donald Easton, Christopher B Granger, Richard A Bernstein, Shinichiro Uchiyama, Jörg Kreuzer, et al. 2019. “Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.” The New England Journal of Medicine 380 (20): 1906–17. doi:10.1056/NEJMoa1813959.